Erste Asset Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.45M | Buy |
81,606
+28,375
| +53% | +$2.53M | 0.07% | 247 |
|
|
2026
Q1 | $3.73M | Sell |
53,231
-171
| -0.3% | -$13.2K | 0.03% | 297 |
|
|
2025
Q4 | $4.27M | Buy |
53,402
+26,059
| +95% | +$2.05M | 0.04% | 290 |
|
|
2025
Q3 | $2.07M | Sell |
27,343
-17,762
| -39% | -$1.22M | 0.02% | 345 |
|
|
2025
Q2 | $3.09M | Buy |
45,105
+31,127
| +223% | +$2.04M | 0.03% | 338 |
|
|
2025
Q1 | $938K | Sell |
13,978
-2,714
| -16% | -$162K | 0.01% | 383 |
|
|
2024
Q4 | $743K | Sell |
16,692
-82,829
| -83% | -$4.65M | 0.01% | 414 |
|
|
2024
Q3 | $6.11M | Buy |
99,521
+10,519
| +12% | +$614K | 0.07% | 220 |
|
|
2024
Q2 | $5.19M | Sell |
89,002
-28,165
| -24% | -$1.76M | 0.07% | 217 |
|
|
2024
Q1 | $9.31M | Buy |
117,167
+2,009
| +2% | +$153K | 0.13% | 164 |
|
|
2023
Q4 | $9.09M | Buy |
115,158
+16,098
| +16% | +$1.15M | 0.13% | 159 |
|
|
2023
Q3 | $6.94M | Buy |
99,060
+5,336
| +6% | +$378K | 0.12% | 175 |
|
|
2023
Q2 | $6.44M | Sell |
93,724
-34,114
| -27% | -$2.43M | 0.11% | 187 |
|
|
2023
Q1 | $9.53M | Buy |
127,838
+2,003
| +2% | +$168K | 0.18% | 136 |
|
|
2022
Q4 | $11.7M | Sell |
125,835
-3,865
| -3% | -$373K | 0.25% | 111 |
|
|
2022
Q3 | $12.5M | Sell |
129,700
-1,067
| -0.8% | -$106K | 0.28% | 100 |
|
|
2022
Q2 | $12.2M | Sell |
130,767
-7,582
| -5% | -$740K | 0.27% | 103 |
|
|
2022
Q1 | $14.2M | Sell |
138,349
-6,605
| -5% | -$694K | 0.27% | 100 |
|
|
2021
Q4 | $15M | Sell |
144,954
-1,863
| -1% | -$172K | 0.27% | 104 |
|
|
2021
Q3 | $12.7M | Buy |
146,817
+8,589
| +6% | +$719K | 0.25% | 117 |
|
|
2021
Q2 | $11.5M | Buy |
138,228
+66,265
| +92% | +$5.43M | 0.23% | 121 |
|
|
2021
Q1 | $5.46M | Buy |
71,963
+6,020
| +9% | +$439K | 0.13% | 173 |
|
|
2020
Q4 | $4.47M | Buy |
65,943
+25,886
| +65% | +$1.68M | 0.12% | 181 |
|
|
2020
Q3 | $2.3M | Buy |
40,057
+4,234
| +12% | +$263K | 0.08% | 229 |
|
|
2020
Q2 | $2.31M | Sell |
35,823
-1,300
| -4% | -$81.9K | 0.09% | 213 |
|
|
2020
Q1 | $2.22M | Sell |
37,123
-387,910
| -91% | -$25.9M | 0.13% | 177 |
|
|
2019
Q4 | $31.4M | Buy |
425,033
+7,500
| +2% | +$527K | 1.39% | 17 |
|
|
2019
Q3 | $26.3M | Buy |
417,533
+387,300
| +1,281% | +$23M | 1.4% | 18 |
|
|
2019
Q2 | $1.65M | Hold |
30,233
| – | – | 0.09% | 200 |
|
|
2019
Q1 | $1.61M | Buy |
30,233
+690
| +2% | +$42.6K | 0.09% | 197 |
|
|
2018
Q4 | $1.93M | Buy |
+29,543
| New | +$2.21M | 0.13% | 157 |
|
Other funds holding CVS
Erste Asset Management's CVS Position: Q2 2026 in Review
Erste Asset Management increased its CVS Health (CVS) stake by 53% in Q2 2026, buying an estimated $2.53M and bringing the position to 81,606 shares worth $8.45M. The position accounts for 0.07% of the portfolio, ranked #247.
Erste Asset Management first reported a position in CVS in Q4 2018 and has held it in 31 quarters since. The position peaked at $31.4M in Q4 2019. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Erste Asset Management held 81,606 shares of CVS Health worth $8.45M as of Q2 2026.
- Erste Asset Management bought 28,375 CVS Health shares in Q2 2026, an estimated $2.53M.
- CVS Health made up 0.07% of Erste Asset Management's portfolio in Q2 2026, its #247 holding.
- Erste Asset Management first reported a position in CVS Health in Q4 2018 and has held it in 31 quarters since.
- Erste Asset Management's CVS Health position peaked at $31.4M in Q4 2019.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Erste Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.